News Square
Global Crypto News · Real-time Aggregation
📚 Deep Analysis
More →GRVT Burns 1.1 Million Tokens as Countdown to Grvt 2.0 Begins
<strong>[PRESS RELEASE – Singapore, Singapore, October 20th, 2026]</strong> <strong>The discretionary buyback represents close to 1% of circulating supply and precedes four planned product milestones culminating in Grvt 2.0.</strong> <a href="https://grvt.io/" rel="nofollow noopener" target="_blank">>Grvt</a>, a self-custodial trading platform built on its own zero-knowledge (ZK) chain, announced that the Foundation’s token issuer has completed its first GRVT token buyback, purchasing and burning 1.1 million GRVT tokens on the open market. The transaction permanently removed close to 1% of GRVT’s circulating supply at the time of purchase. It marks the first of five milestones ahead of the planned launch of Grvt 2.0 at the end of November 2026. <strong>A Discretionary Buyback with On-Chain Verification</strong> The Foundation’s token issuer intends to conduct further buybacks on a monthly basis. Each transaction remains entirely at the issuer’s discretion, with no predetermined purchase amount or guaranteed schedule. Buybacks are executed through an independent execution partner, with purchased tokens transferred to a designated burn address and permanently removed from circulation. The transactions can be independently verified through the <a href="https://grvt.io/exchange/buybacks" rel="nofollow noopener" target="_blank">>public buyback dashboard</a>, which records the number of tokens purchased and burned, the percentage of circulating supply represented, cumulative burns and on-chain transaction hashes. “The GRVT token is an important part of the ecosystem we are building,” said <strong>Hong, co-founder and CEO of Grvt</strong>. “We welcome the issuer’s buybacks as a demonstration of its long-term commitment to the ecosystem and community. Grvt is expanding its products and markets, and the issuer’s buybacks sit alongside that as a supportive mechanism aimed at reducing circulating token supply.” <strong>Grvt Outlines Four Product Milestones</strong> The announcement follows GRVT’s token generation event in July 2026 and precedes a series of planned launches. <strong>Grvt Earn, scheduled for the End of October,</strong> will introduce yield opportunities backed by tokenized assets, with target yields of up to 11%. Potential returns are expected to derive from underlying asset cash flows, including interest, premiums and invoice-related income. Asset-supplying partners will be announced at launch. Target yields are not guaranteed. <strong>Stable Funding Perps, scheduled for November,</strong> will introduce perpetual futures linked to commodities, stocks, foreign exchange and indices. The contracts are planned to carry zero trading fees and use once-daily funding. Grvt aims to list more than 1,000 markets by the end of December 2026. <strong>Yield as Margin, also scheduled for November,</strong> will allow eligible Grvt Earn balances to support trading positions while continuing to accrue yield, subject to applicable product terms
OpenAI Buys Orchestra Bio to Put AI Agents in Charge of Drug Development Grunt Work
OpenAI has bought Orchestra Bio, a San Francisco startup whose AI agents help drug companies keep sprawling development programs on schedule, the ChatGPT maker <a href="https://openai.com/index/openai-to-acquire-orchestra-bio/" target="_blank" rel="nofollow external noopener" class="sc-adb616fe-0 dJryYS">>announced Tuesday</a>. “Our goal is to help scientists make discoveries and manage the work needed to turn them into treatments that reach patients sooner,” OpenAI said in the announcement. Orchestra’s team and platform will be folded into <a href="https://openai.com/rosalind/" target="_blank" rel="nofollow external noopener" class="sc-adb616fe-0 dJryYS">>Rosalind</a>, OpenAI’s family of AI models and tools for biologists and chemists. The financial terms were not disclosed. Getting a new medicine from first idea to U.S. approval takes time—up to 15 years according to OpenAI. Every month shaved off that timeline is a month earlier that a new treatment can reach the people waiting for it, and a month earlier that the company can generate cash. The process is also absurdly expensive: bringing one approved drug to market can cost more than <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12668846/" target="_blank" rel="nofollow external noopener" class="sc-adb616fe-0 dJryYS">>$2.6 billion</a>, and <a href="https://arxiv.org/pdf/2106.05386" target="_blank" class="sc-adb616fe-0 dJryYS" rel="nofollow">fewer than 10%</a> of candidates that enter human testing ever make it to pharmacy shelves. Beyond the science itself, OpenAI says drug teams have to coordinate work across internal departments and outside partners, often relying on systems that don’t talk to each other. Those partners usually include contract research organizations, the outside labs hired to run studies, and contract manufacturers that produce the experimental drug. Orchestra’s AI agents—software that can watch over tasks and flag problems on its own—work out which activities and deadlines take the hit, gather the relevant information and compare ways to respond, while scientists and program leaders make the final call. Founded in the fall of 2022, Orchestra raised its <a href="https://jobs.8vc.com/companies/orchestra/jobs/28818089-senior-software-engineer" target="_blank" rel="nofollow external noopener" class="sc-adb616fe-0 dJryYS">>seed round</a> from Andreessen Horowitz, Definition Capital, Insight Partners, and 8VC, and about $20 million in total, according to <a href="https://www.caplight.com/company/orchestra-bio" target="_blank" class="sc-adb616fe-0 dJryYS" rel="nofollow">Caplight data</a>. The company should not be confused with Orchestra BioMed, an unrelated Nasdaq-listed medical device maker that trades under the ticker OBIO. In April, OpenAI launched <a href="https://decrypt.co/364783/openai-gpt-rosalind-drug-discovery-life-sciences-model" target="_blank" class="sc-adb616fe-0 dJryYS" rel="nofollow">GPT-Rosalind</a>, a model built specifically for biology and dru
Multiple Japanese civil society groups will hold rallies to oppose the government's military expansion and constitutional revision.
CoinWorld news: Multiple Japanese civil groups plan to hold rallies on the 21st in Tokyo, Osaka, Gunma, Fukuoka, and other locations to oppose the dangerous moves by the Japanese government to amend the constitution and expand the military, and to call for safeguarding the pacifist constitution and opposing war.
Ukrainian authorities say Russian drone strikes on Kharkiv region overnight killed two people.
Ukrainian authorities say Russian drone strikes on Kharkiv region overnight killed two people, according to BiJie Network.
Singapore's DayOne reconsiders US IPO plan.
Singapore's DayOne Data Centers Ltd. is reassessing its U.S. initial public offering (IPO) plans amid turmoil in the data center industry, including possibly delaying the listing or scaling back the fundraising size. People familiar with the matter said the company has been waiting for the right moment to launch the IPO while considering the possibility of proceeding after the market recovers. Other options include listing at a smaller scale, with fundraising potentially between $2.5 billion and $3 billion, roughly only half of its original target amount. DayOne, whose investors include Coatue and Hillhouse Capital, is still in contact with potential investors and hopes to move forward with the listing as soon as market conditions allow. People familiar with the matter previously said the company initially planned to raise as much as $5 billion through the listing as early as the fourth quarter and had sought a valuation of about $20 billion.
The core trading volume of the main meme market reached 272 million USD.
CoinWorld data: According to the gmgn 24h trading volume ranking, as of 10:02 on October 21, the core trading volume of major meme markets such as Solana, Robinhood, and BNB was approximately $272 million, with the three accounting for about $160 million, $76.25 million, and $25.07 million respectively, representing 58.7%, 28.0%, and 9.2%. The trading volume of major meme markets grew 20.2% day-over-day, with Solana seeing the highest increase at 32.8% day-over-day. Wu Shuo reminds that meme coins are extremely volatile and high-risk, so please do not follow blindly.
The number of declining stocks listed on the Nasdaq is reported at 3,649.
CoinWorld US stock data: Nasdaq securities declining today totaled 3,649. Compared with the same-caliber snapshot 7 days ago, this is up 74.59%.
Binance Futures will list multiple traditional finance USDⓢ-margined perpetual contracts.
Binance Futures will launch multiple traditional finance USDⓢ-margined perpetual contracts on October 21, 2026, according to Bijie.com.
The long-to-short account ratio for SOL perpetual contracts is 2.54.
CoinWorld data: The SOLUSDT 4-hour long-short account ratio is 2.54, with more net long accounts than net short accounts. Compared with the same-caliber snapshot 24 hours ago, it rose by 0.1272; compared with the same-caliber snapshot 7 days ago, it rose by 0.1891.
Tom Lee的Bitmine再次质押159,728枚以太坊
BiJie Network data: According to Cointelegraph, Tom Lee's Bitmine has once again staked 159,728 ETH, worth approximately $390.6 million, bringing its total staked amount to 5.23 million ETH, accounting for 86.5% of its holdings.